Endometrial Cancer
📧 Sign up to get email alerts when something new happens for Endometrial Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-03-18Clinical Trial Update: Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer [Phase 3]
Phase 3 trial evaluating adding pembrolizumab to paclitaxel and carboplatin for stage III-IV or recurrent endometrial cancer.
-
CLINICAL_TRIALS trial_result · 2025-03-18Clinical Trial Update: Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer [Phase 3]
Phase 3 trial updating the addition of pembrolizumab to standard chemotherapy (paclitaxel and carboplatin) for stage III-IV or recurrent end…
-
CLINICAL_TRIALS research · 2025-03-14Clinical Trial Update: Bariatric Surgery for Fertility-Sparing Treatment of Atypical Hyperplasia and Grade 1 Cancer of the Endometrium [NA]
A clinical trial is evaluating bariatric surgery as a fertility-sparing treatment option for endometrial cancer (Grade 1) and endometrial hy…
-
CLINICAL_TRIALS trial_result · 2025-03-14Clinical Trial Update: Near-Infrared Fluorescence Imaging With Indocyanine Green to Evaluate Bowel Anastomoses in Gynecologic Oncology Surgery [Phase 4]
This Phase 4 clinical trial update describes using near-infrared fluorescence imaging with indocyanine green to evaluate bowel anastomoses i…
-
CLINICAL_TRIALS trial_result · 2025-03-12Clinical Trial Update: Effect of Pelvic Radiotherapy on the Intestinal Microbiome and Metabolome
This completed trial evaluated the effect of pelvic radiotherapy on the intestinal microbiome and metabolome in patients with bladder cancer…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-03-07Clinical Trial Update: BP1001-A in Patients With Advanced or Recurrent Solid Tumors [Phase 1]
This clinical trial update states that BP1001-A is being evaluated in a Phase 1 study for advanced or recurrent solid tumors and is currentl…
-
CLINICAL_TRIALS research · 2025-03-07Clinical Trial Update: Molecular and Epidemiological Characteristics of Endometrial Cancer in Brazil
This clinical trial update outlines a study on the molecular and epidemiological characteristics of endometrial cancer in Brazil, sponsored …
-
CLINICAL_TRIALS research · 2025-03-07Clinical Trial Update: Uterine Manipulator Versus No Uterine Manipulator in Endometrial Cancer Trial [NA]
Clinical trial update comparing the use of a uterine manipulator versus no uterine manipulator in endometrial cancer. The study is currently…
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: Tazemetostat in Treating Patients With Recurrent Ovarian or Endometrial Cancer [Phase 2]
This is a Phase 2 clinical trial evaluating tazemetostat for recurrent ovarian or endometrial cancers; the study is currently not recruiting…
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: PRospective REgistry of Advanced Stage CancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision Medicine
A completed multicancer registry study (PREFER) assessing the prevalence of actionable biomarkers and driver mutations across advanced cance…
-
CLINICAL_TRIALS trial_result · 2025-03-04Clinical Trial Update: Study of Copanlisib and Ketogenic Diet [Phase 2]
A Phase 2 study evaluating copanlisib in combination with a ketogenic diet for follicular lymphoma and endometrial cancer was terminated, wi…
-
CLINICAL_TRIALS trial_result · 2025-02-28Clinical Trial Update: Study of AK112 in the Treatment of Advanced Gynecological Tumors [Phase 2]
Phase 2 study of AK112 for advanced gynecologic tumors has been completed, evaluating efficacy in ovarian, cervical, and endometrial cancers…
-
CLINICAL_TRIALS research · 2025-02-28Clinical Trial Update: Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
Northwestern University is conducting a specimen and data study for ovarian cancer early detection and prevention. The trial is currently re…
-
CLINICAL_TRIALS research · 2025-02-24Clinical Trial Update: A.I and Machine Learning Based Risk Prediction Model to Improve the Clinical Management of Endometrial Cancer.
A clinical trial is evaluating an AI and machine learning-based risk prediction model to improve the clinical management of endometrial canc…
-
CLINICAL_TRIALS research · 2025-02-21Clinical Trial Update: Genetic Testing in African Americans [NA]
Clinical trial update on genetic testing in African American participants related to ovarian cancer, endometrial cancer, and peritoneal canc…
-
CLINICAL_TRIALS research · 2025-02-19Clinical Trial Update: Sentinel Lymph Node Sampling for Patients With Middle-high Risk Endometrial Cancer Confined to the Uterus [NA]
Clinical trial status update for a study evaluating sentinel lymph node sampling in middle-high risk endometrial cancer confined to the uter…
-
CLINICAL_TRIALS trial_result · 2025-02-13Clinical Trial Update: Mirvetuximab Soravtansine and Rucaparib Camsylate in Treating Participants With Recurrent Endometrial, Ovarian, Fallopian Tube or Primary Peritoneal Cancer [Phase 1]
A Phase 1 trial evaluates the combination of mirvetuximab soravtansine and rucaparib camsylate in patients with recurrent gynecologic cancer…
-
CLINICAL_TRIALS trial_result · 2025-02-13Clinical Trial Update: Tislelizumab for the Treatment of Recurrent Mismatch Repair Deficient Endometrial Cancer [EARLY_Phase 1]
Early-phase trial update shows termination of a tislelizumab study for recurrent mismatch repair-deficient endometrial cancer.
-
CLINICAL_TRIALS trial_result · 2025-02-10Clinical Trial Update: A Study of SGN-ALPV in Advanced Solid Tumors [Phase 1]
Seagen's Phase 1 study of SGN-ALPV in advanced solid tumors has been terminated; the trial evaluated multiple cancers including ovarian, end…
-
CLINICAL_TRIALS trial_result · 2025-02-07Clinical Trial Update: A Study of SGN-STNV in Advanced Solid Tumors [Phase 1]
Seagen's Phase 1 study of SGN-STNV in advanced solid tumors has been terminated.
-
CLINICAL_TRIALS research · 2025-02-07Clinical Trial Update: A Study of XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies [Phase 2]
This clinical trial update reports on a Phase 2 study of XmAb20717 (Vudalimab) in selected advanced gynecologic and genitourinary cancers, w…
-
CLINICAL_TRIALS research · 2025-01-30Clinical Trial Update: Evaluating Efficacy and Tolerability of Anticancer Drug Therapies for the Treatment of Gynecologic and Breast Cancers
This clinical trial update shows recruitment for evaluating efficacy and tolerability of anticancer drug therapies in breast and gynecologic…
-
CLINICAL_TRIALS research · 2025-01-30Clinical Trial Update: Methylated Biomarkers Predictive of Endometrial Cancer Risk
A clinical trial update from the University of Manchester describes methylated biomarkers that may predict endometrial cancer risk. The stud…
-
CLINICAL_TRIALS trial_result · 2025-01-23Clinical Trial Update: Validation Study on the Removal of EpCAM-positive Tumour Cells From Blood Collected During Tumour Surgery Using Catumaxomab/Catuvab Device [NA]
A completed validation trial evaluated removal of EpCAM-positive tumor cells from blood collected during tumor surgery using the Catumaxomab…
-
CLINICAL_TRIALS research · 2025-01-23Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of HB0025 Injection in Patients With Advanced Solid Tumor [Phase 1, Phase 2]
A Phase 1/2 clinical trial assessing the safety and preliminary efficacy of HB0025 injection in patients with advanced solid tumors, includi…